2511 — HighTide Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- HK$3.05bn
- HK$2.28bn
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PRESS |
Standards: | IFRS | IFRS | — |
Status: | Final | Final | Final |
Cash | |||
Short Term Investments | |||
Cash and Short Term Investments | 765 | 840 | 736 |
Net Total Receivables | 3.64 | 2.34 | — |
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 775 | 851 | 779 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 3.45 | 4.81 | 15 |
Other Long Term Assets | |||
Total Assets | 779 | 856 | 795 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 28.5 | 1,320 | 79.8 |
Long Term Debt | |||
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Total Other Liabilities | |||
Total Liabilities | 1,051 | 1,326 | 92.3 |
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Treasury Stock | |||
Other Equity | |||
Total Equity | -272 | -471 | 703 |
Total Liabilities & Shareholders' Equity | 779 | 856 | 795 |
Total Common Shares Outstanding |